For crystalline, semi-crystalline, and even amorphous samples, Bruker X-ray diffractometers can produce beam-optimized scans to support pharmaceutical product development. The instrument family provides both multipurpose and dedicated solutions for more specific applications in materials characterization.
Pharmaceutical development brings new challenges to light: crystalline polymorphs, thin-films, excipient analysis. Integration of this important physical characterization data underlies product formulation, consistency, and eventual FDA submission documentation. Using the Tetra Data Platform allows for integration of these data against other parameters such as mass spec or DSC to get a fuller picture of your drug substance.
Get in touch with a Solution Architect for a demo of this integration. Fill in the form and we'll reach out to you as soon as possible.
Since launching Tetra 2.0 our growth metrics have been simply remarkable, with 2020 ARR growing 10x over 2019 and 2021 ARR growth expected to increase another 3x over 2020.
Category Kings and Queens dominate in the winner-take-all world of tech economics in which they capture virtually all of a market's mindshare, market share, margin, and market capitalization.
We are incredibly excited and profoundly grateful to announce the closing of our $80 million Series B which was co-led by Insight Partners and Alkeon Capital.
Tasks take seconds, not hours, by eliminating manual data processing
Tasks take seconds, not hours, by eliminating manual data processing
Empowering Alexion Scientists to probe their data through intuitive data applications
Empowering Alexion Scientists to probe their data through intuitive data applications
Enabling FAIR access to pharmacokinetic and pharmacodynamic results
Enabling FAIR access to pharmacokinetic and pharmacodynamic results
*References here in no way indicate any formal relationship or endorsement by the respective companies
